Expand INCY Menu
INCY MENU

INCY Stock Summary and Trading Ideas (Incyte | NASDAQ:INCY)

Charts for Today's Stock Price and Implied Volatility in Incyte

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for INCY by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Incyte (INCY) Frequently Asked Questions

What does Incyte do?

Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.

What symbol and exchange does Incyte stock trade?

Incyte trades on the NASDAQ stock market under the symbol INCY.

What is Incyte stock price doing today?

As of April 23, 2024, INCY stock price declined to $51.65 with 2,218,262 million shares trading.

What is Incyte's Beta?

INCY has a beta of 0.88, meaning it tends to be less sensitive to market movements. INCY has a correlation of 0.18 to the broad based SPY ETF.

How much is Incyte worth?

INCY has a market cap of $11.60 billion. This is considered a Large Cap stock.

How much money does Incyte make?

Last quarter Incyte reported $1 billion in Revenue and $1.06 earnings per share. This beat revenue expectation by $13 million and missed earnings estimates by -$.10.

What is the highest and lowest price Incyte traded in the last 3 year period?

In the last 3 years, INCY stock traded as high as $88.26 and as low as $50.27.

What are the top ETFs holding Incyte?

The top ETF exchange traded funds that INCY belongs to (by Net Assets): VTI, VOO, VO, SPY, USMV.

Is Incyte (INCY) a good investment?

INCY has underperformed the market in the last year with a price return of -30.8% while the SPY ETF gained +24.3%. INCY has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -16.0% and -6.2%, respectively, while the SPY returned +4.9% and -2.5%, respectively.

What is the support and resistance for Incyte (INCY) stock price?

INCY support price is $51.25 and resistance is $52.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that INCY stock will trade within this expected range on the day.